We are live on ! Find out more
LAB icon

Standard BioTools
LAB

83 hedge funds and large institutions have $196M invested in Standard BioTools in 2016 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 26 increasing their positions, 27 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

92.38% more ownership

Funds ownership: 0% → 92.38% (+92%)

7% more capital invested

Capital invested by funds: $182M → $196M (+$13.3M)

4% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 27

15% less funds holding

Funds holding: 98 → 83 (-15)

43% less call options, than puts

Call options by funds: $74K | Put options by funds: $130K

56% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 25

Holders
83
Holders Change
-15
Holders Change %
-15.31%
% of All Funds
2.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
26
Reduced
27
Closed
25
Calls
$74K
Puts
$130K
Net Calls
-$56K
Net Calls Change
+$167K

Top Buyers

1
LCS
Levin Capital Strategies
New York
+$8.61M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$1.75M
3
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
+$1.08M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$1M
5
Citadel Advisors
Citadel Advisors
Florida
+$709K

Top Sellers

1
Franklin Resources
Franklin Resources
California
-$15.9M
2
Millennium Management
Millennium Management
New York
-$2.38M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$2.31M
4
Lazard Asset Management
Lazard Asset Management
New York
-$2.26M
5
EAM
EverPoint Asset Management
Connecticut
-$1.84M
Name Holding Trade Value Shares
Change 		Change in
Stake
LCS
1
Levin Capital Strategies
New York
$41.9M +$8.61M +1,370,490 +31%
Primecap Management
2
Primecap Management
California
$31.3M +$190K +30,200 +0.7%
Russell Investments Group
3
Russell Investments Group
United Kingdom
$16.1M +$14.1M +2,239,212 New
WA
4
Wasatch Advisors
Utah
$13.5M -$139K -22,204 -1%
O
5
OrbiMed
New York
$12.7M – – –
Neuberger Berman Group
6
Neuberger Berman Group
New York
$8.86M -$246K -39,118 -3%
Vanguard Group
7
Vanguard Group
Pennsylvania
$8.46M +$187K +29,771 +3%
BFA
8
BlackRock Fund Advisors
California
$6.5M +$550K +87,534 +11%
Adage Capital Partners
9
Adage Capital Partners
Massachusetts
$6.4M +$1.75M +278,880 +46%
BIT
10
BlackRock Institutional Trust
California
$5.83M -$34.3K -5,458 -0.7%
Capital World Investors
11
Capital World Investors
California
$5.82M – – –
Wellington Management Group
12
Wellington Management Group
Massachusetts
$4.48M +$88.6K +14,110 +2%
State Street
13
State Street
Massachusetts
$3.39M -$37.5K -5,975 -1%
Renaissance Technologies
14
Renaissance Technologies
New York
$3.29M +$509K +81,000 +22%
Northern Trust
15
Northern Trust
Illinois
$2.67M -$221K -35,237 -9%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$1.56M +$55.9K +8,897 +4%
Acadian Asset Management
17
Acadian Asset Management
Massachusetts
$1.5M -$237K -37,809 -15%
FC
18
FIC Capital
New York
$1.37M – – –
Fuller & Thaler Asset Management
19
Fuller & Thaler Asset Management
California
$1.26M +$1.08M +172,561 New
Bank of New York Mellon
20
Bank of New York Mellon
New York
$1.25M -$127K -20,181 -11%
Norges Bank
21
Norges Bank
Norway
$1.2M – – –
Fidelity Investments
22
Fidelity Investments
Massachusetts
$1.17M +$1M +160,000 New
Goldman Sachs
23
Goldman Sachs
New York
$1.06M +$36.7K +5,848 +4%
Citadel Advisors
24
Citadel Advisors
Florida
$1.04M +$709K +112,847 +381%
IP
25
Intellectus Partners
California
$988K +$852K +135,689 New
1
2 3 4 5

LAB Hedge Fund Activity: Q4 2016 in Review

83 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q4 2016, worth a combined $196M — up 7.3% from $182M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of LAB and 11 opened new positions — a net loss of 14 holders — while 27 trimmed existing stakes and 26 added.

The largest buyer was Levin Capital Strategies, adding an estimated $8.61M. The largest seller was Franklin Resources, exiting entirely with an estimated $15.9M sold.

  • 83 institutional investors held Standard BioTools (LAB) as of Q4 2016, down from 98 in Q3 2016.
  • Funds reported $196M of Standard BioTools stock for Q4 2016, up 7.3% quarter-over-quarter.
  • 11 funds opened new Standard BioTools positions in Q4 2016 and 25 closed out, a net change of -14 holders.
  • The largest Standard BioTools buyer in Q4 2016 was Levin Capital Strategies, an estimated $8.61M added.
  • The largest Standard BioTools seller in Q4 2016 was Franklin Resources, an estimated $15.9M sold.

Based on aggregated 13F filings for Q4 2016.